Whilst I agree with the sentiment, I think the reason why so many are nervous (and even potentially against going alone) is the fear of not see the SP appreciate during P3 and PRIOR to results. If phase 3 is successful, then any significant rerate may only be after FDA approval - which then adds even more time to an already long wait!
Someone previously shared detailed SP movements during phase 3 trials and from memory, the share price almost always declined throughout the process in the lead up to results
Although in saying that, perhaps it's different this time given the comparison and success of Daybue to peg 2591 to - here's hoping!!
Share Price, page-11809
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.36 |
Change
-0.450(3.26%) |
Mkt cap ! $1.726B | |||
| Open | High | Low | Value | Volume |
| $13.82 | $13.91 | $13.32 | $3.664M | 269.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27 | $14.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.03 | 1364 | 1 |
View Market Depth
| Last trade - 15.59pm 11/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |